netFormulary Birmingham, Sandwell, Solihull and environs APC Formulary NHS
Maintained by Midlands and Lancashire Commissioning Support Unit  
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.04.02  Expand sub section  Drugs for urinary frequency, enuresis, and incontinence
07.04.02  Expand sub section  Urinary incontinence
Oxybutynin (immediate release tablets)
View adult BNF View SPC online View childrens BNF
First Choice
Green
  • 2.5mg and 5mg tablets only

  • 3mg tablets are non-formulary 
  • Oxybutynin (Modified release tablets)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    High Cost Medicine
     
       
    Oxybutynin Hydrochloride patch (Kentera)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
  • for patients who cannot tolerate oral agents 
  •    
    Tolterodine tablets
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
     
       
    Tolterodine modified -release capsules
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
    High Cost Medicine
     
       
    Trospium
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
  • for patients over 65 years of age 
  •    
    Trospium (Regurin XL )
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
  • for patients over 65 years of age 
  •    
    Mirabegron (Betmiga)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Green
  • for patients not tolerating/ with contra-indications to antimuscarinics
  • in line with NICE 
  • Link  MHRA alert (Oct 2015): Mirabegron (Betmiga▼): risk of severe hypertension and associated cerebrovascular and cardiac events
    Link  NICE TA290: Mirabegron for overactive bladder
       
    Solifenacin (Vesicare)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Amber
    High Cost Medicine
  • place in therapy is after agents that have effectiveness at lower costs 
  •    
    Duloxetine (Yentreve)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
     
       
    07.04.02  Expand sub section  Nocturnal enuresis
     ....
     Non Formulary Items
    Darifenacin  (Emselex)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Fesoterodine  (Toviaz)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Flavoxate  (Urispas 200)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Imipramine

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Oxybutynin Intra-vesical

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Propantheline

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Propiverine  (Detrunorm)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
    Solifenacin and Tamsulosin  (Vesomni)

    View adult BNF View SPC online View childrens BNF
    Non Formulary
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Green

    Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

    Amber

    Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

    Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

    Red

    Medicines for initiation and maintenance prescribing by Specialists only  

    Black

    Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

    Grey

    Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

    netFormulary